/KASE, June 7, 2024/ – Black Biotechnology LLP (Almaty), whose bonds are officially listed on Kazakhstan Stock Exchange (KASE), has provided KASE with an auditor's report on the company's financial statements for 2023.

According to the audited data as of December 31, 2023 (in th. tenge, if not otherwise specified):

----------------------------------------
                          as of    as of
Indicator              31.12.23 31.12.22
--------------------- --------- --------
Equity                    7,583  -39,971
Total assets          1,965,079  117,378
Total liabilities     1,957,496  157,349
Sales volume            154,872   39,529
Gross margin            102,674   20,651
Net income (net loss)   -13,668  -37,636
ROA, %                    -0.70   -32.06
ROE, %                  -180.25    94.16
ROS, %                    -8.83   -95.21
----------------------------------------

The company's financial statements for 2023 were audited by Audit company "Solomon" LLP. According to the auditor's opinion, the financial statements present fairly the financial position of Black Biotechnology LLP in all material aspects as of December 31, 2023, as well as its financial results and cash flows for the year ended as of the specified date in accordance with IFRS.

The report is available on KASE website at – see more

[2024-06-07]